In addition, downregulation of TNS1, TNS2 or TNS3 reduces the invasiveness of ovarian and breast cancer cell lines by impairing integrin internalization and focal adhesion turnover [47,48,49]. This evidence concerns the gene TNS2 and breast cancer.